Non-recourse financing exists specifically for the situation where you have valuable but illiquid options, not enough cash to exercise and cover the tax bill, and no interest in taking on debt you’d owe regardless of outcome. This post covers how it’s structured, what it actually costs, and how it compares to simply not exercising at all.
How does non-recourse financing actually work?
A specialty finance firm advances you cash, covering some or all of your exercise cost and sometimes your estimated tax liability, in exchange for a contractual right to a share of your proceeds if and when your shares become liquid, whether through an acquisition, an IPO, or a secondary sale. If the company fails or never has a liquidity event, the financing is “non-recourse,” meaning the firm can’t come after your other assets to recover what they advanced. You keep the exercised shares in your name, but the firm has a claim against future proceeds.
What does “non-recourse” actually protect me from?
It protects you from owing money back out of pocket if the company’s value never materializes. Unlike a traditional loan, where you’re on the hook for repayment regardless of what happens to the underlying shares, non-recourse financing ties repayment entirely to the shares’ eventual value. If that value is zero, the firm generally absorbs the loss, not you.
What does this protection actually cost?
Once origination fees, ongoing costs, and the provider’s contractual share of your eventual proceeds are all added up, non-recourse financing commonly costs somewhere between 20% and 50% of what your shares end up being worth, taken off the top before you see any of it. Some structures charge a flat fee plus a percentage of upside above a set return threshold; others are structured more like a prepaid forward contract, where the firm effectively buys a defined slice of your future proceeds upfront. The exact structure and total cost vary significantly by provider and by deal.
When does this arrangement make the most sense?
It tends to make the most sense when you couldn’t otherwise afford to exercise a meaningful position at all, meaning the alternative isn’t “pay cash instead” but “let the options expire entirely.” In that comparison, giving up a portion of the upside in exchange for keeping some position, with no personal financial risk if things don’t work out, can be a reasonable tradeoff. For a smaller exercise you could otherwise cover in cash or with a modest personal loan, the cost of non-recourse financing is often higher than those simpler alternatives.
What happens to my shares under this arrangement?
You typically still hold legal ownership of the exercised shares, but the financing agreement usually includes contractual rights for the provider around your eventual sale, transfer, or exit event, meaning you’re not entirely free to do whatever you want with the shares without the provider’s involvement. Read the specific agreement closely, since these terms vary by provider.
Worked example
Say you need $60,000 to exercise a block of options and expect a further tax bill on top of that, more than you can cover in cash. You take non-recourse financing covering the full $80,000 (exercise cost plus estimated tax), structured to cost 30% of your proceeds at whatever future liquidity event occurs.
If the company is eventually acquired and your shares are worth $500,000 at that point, the financing provider would take 30%, or $150,000, leaving you with $350,000, compared to the $80,000 you would have needed to find in cash upfront. If the company fails and the shares are worth nothing, you generally owe nothing back, having paid nothing out of pocket beyond whatever the agreement’s fees required at the start.
FAQ
Is non-recourse financing the same as a loan? No. A traditional loan requires repayment regardless of outcome. Non-recourse financing ties repayment to your shares actually becoming liquid and valuable, with no personal obligation if they don’t.
How much of my future proceeds will a provider typically take? It varies by provider and deal structure, but the effective cost commonly lands between 20% and 50% of eventual share value once all fees and terms are factored in.
Can I use non-recourse financing for a small exercise? You can, but the relatively high effective cost often makes it less attractive for smaller exercises you could otherwise cover with cash or a personal loan.
Do I still own my shares if I use this kind of financing? Generally yes, in your own name, though the financing agreement typically includes contractual rights for the provider that limit your full discretion over the shares until the arrangement is settled.
What happens if the company never has a liquidity event? Under a true non-recourse structure, you typically owe nothing back, since repayment is tied entirely to an actual liquidity event occurring.
What to do next
The specific terms, fees, and repayment structure vary meaningfully between providers, so it’s worth comparing actual offers rather than assuming a single standard cost. You can model your own exercise costs and compare financing scenarios at movewealth.io.
MoveWealth is not a broker-dealer, investment adviser, or lender. This is educational content, not financial, tax, or legal advice. Consult a qualified professional about your specific situation.